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Abstract
Background: We previously reported that periplakin (PPL) is downregulated in human esophageal cancer tissues
compared to the adjacent non-cancer epithelium. Thus PPL could be a useful marker for detection of early
esophageal cancer and evaluation of tumor progression, but largely remains unknown in this field. To investigate
PPL involvement in carcinogenesis, tumor progression, cellular movement or attachment activity, siRNAs against
PPL were transfected into pharyngeal squamous cancer cell lines and their effects on cellular behaviours were
examined.
Results: PPL knockdown appeared to decrease tumor cell growth together with G2/M phase accumulation in cells
attached to a culture dish. However, the extent of cell growth suppression, evaluated by the number of cells
attached to the culture dish, was too distinctive to be explained only by cell cycle delay. Importantly, PPL
knockdown suppressed cellular movement and attachment to the culture dish accompanied by decreased
pAktSer473 phosphorylation. Additionally, LY294002, a PI3K inhibitor that dephosphorylates pAktSer473, significantly
suppressed D562 cell migration. Thus PPL potentially engages in cellular movement al least partly via the PI3K/Akt
axis.
Conclusions: PPL knockdown is related to reduced cellular movement and attachment activity in association with
PI3K/Akt axis suppression, rather than malignant progression in pharyngeal cancer cells.
Background
Pharyngeal and esophageal cancers are some of the most
malignant gastrointestinal tumors [1]. We previously
reported that a cell adhesion molecule, periplakin (PPL),
is significantly downregulated in human esophageal can-
cers. Immunohistochemical staining has also revealed
that PPL changes its cellular localization as well as its
expression levels with cancer progression [2]. In addi-
tion, PPL expression has been associated with nodal
metastasis [3]. These findings indicate that PPL plays an
important role in the development of esophageal and
pharyngeal squamous cell carcinoma; however, the pre-
cise mechanism remains largely unknown.
PPL is a member of the plakin family comprising des-
moplakin, envoplakin, plectin, and bullous pemphigoid
antigen 1, which have various functions in connecting
cytoskeleton elements to form intercellular junction
complexes [4]. Plakin families also function as “molecu-
lar bridges” of cells that link the intracellular cytoskele-
ton and cell-cell junctions. For example, plectin, one of
the most well-studied plakins, directly interacts with sig-
nal transductions [5,6]. PPL also plays a role as a locali-
zation signal in oncogenic serine/threonine protein
kinase Akt/protein kinase B (PKB)-mediated signaling in
human cancer cell lines [7]. Here, Akt/PKB is a down-
stream effector of phosphatidylinositol 3’ kinase (PI3K)
and functions as a critical regulator of cell survival and
proliferation. Furthermore, activation of the PI3K/Akt/
PKB pathway is emerging as a central feature of epithe-
lial-mesenchymal transition (EMT), which is believed to
be a crucial event in tumor development [8].
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In this study, we examined changes in cell growth,
morphology, migration, and attachment activity follow-
ing siRNA against PPL to investigate the involvement of
PPL in tumor development. We found that PPL knock-
down was related to a reduction in cellular movement
and attachment activity, and was accompanied by PI3K/
Akt axis suppression in pharyngeal cancer cells; it was
potentially related to EMT promotion.
Results
Knockdown of PPL expression reduced the number of
cells attached to the culture dish
Since PPL expression is decreased in esophageal carci-
noma tissues [2], we tried to determine the effects of
PPL downregulation on cancer cell activities. First,
endogenous PPL expression in hypopharyngeal squa-
mous carcinoma (D562 and FaDu) and esophageal squa-
mous carcinoma (YES5, TE2, TE4, TE9, TE11, and
TTn) cells was examined (Figure 1A). D562 cells were
selected because siRNA against PPL was most efficient
among these cell lines (Figure 1B, data not shown). In
D562 cells, PPL siRNA inhibited cell growth and
reduced the number of cells attached to the culture dish
(Figure 1C).
Knockdown of PPL expression increased the proportion
of G2/M phase cells attached to the culture dish
So why was the number of attached cells to the culture
dish reduced after PPL downregulation? To determine
the mechanism behind this phenomenon, we first ana-
lyzed the cell cycle populations after PPL siRNAs were
transfected into D562 cells. Compared to control
(GL2) siRNA, cultures treated with PPL siRNA had a
decreased G1 (2N) and an increased late S and G2/M
cell population (Figure 2A). To verify this result, we
further developed a double channel, BrdU and 7-
amino-actinomycin D (7-AAD), flow cytometry proto-
col. By plotting BrdU incorporation (S phase cells) on
the y-axis and 7-AAD (DNA content) on the x-axis,
the cells could be divided into 3 populations: G1, S,
and G2/M (Figure 2B, right). Thus, knockdown of PPL
reduced the S population and increased the G2/M
population (Figure 2C). In particular, the G2/M popu-
lation increased 12.9% in the control cell culture and
15.6% in the PPL siRNA cell culture, a 20.9% increase
(average of siRNA1 and siRNA2). These data suggest
that PPL siRNA decreased cellular proliferation of
D562 cells, at least partly by delay in the G2/M phase
of cells attached to the culture dish. However, to
determine the effect of PPL knockdown on cell growth
more precisely, cells detached from the culture dish
will need to be examined along with cells attached to
the culture dish.
Knockdown of PPL reduced cell adhesion activity
Although siRNA against PPL increased the G2/M phase
population, the decrease in the number of cells grown
on the culture dish was more remarkable (Figure 1C).
Nonetheless, PPL siRNA did not increase apoptosis
when this was assessed by an Apopercentage assay™
(Biocolor Ltd., Newtownabbey, Northern Ireland, UK;
data not shown). How then should we explain the
reduction in the number of attached cells? Possible
explanations include cell growth suppression, cell cycle
retardation, or detachment from the culture dish. There-
fore, we next examined the effects of PPL downregula-
tion on adhesion to the extracellular matrix (ECM) by
an adhesion assay. Cells transfected with PPL siRNA
decreased their attachment to ECM compared with con-
trols (Figure 3A). In order to confirm this result, we
performed an ethylenediaminetetraacetic acid (EDTA)
assay in which EDTA was used to gently block adhesion
of D562 cells to ECM during a 1-h incubation at 37°C.
Interestingly, PPL siRNA-treated and control cells lost
cell-cell and cell-substrate adhesion and changed from
elongated to spherical shape (Figure 3B). However, 6 h
after the release of EDTA, control cells recovered their
ability to adhere to ECM and began to reproliferate
(Additional file 1). In contrast, PPL siRNA-treated cells
remained spherical and did not proliferate, suggesting
that PPL siRNA significantly attenuated cellular adhe-
sion to ECM (Additional file 2). These data suggest that
knockdown of PPL decreases cellular adhesion to ECM
in D562 cells.
Knockdown of PPL reduces cell migration activity
Cell migration is essential for the invasion and metasta-
sis of cancer cells. Thus, to evaluate the effects of PPL
downregulation, a wound-healing assay was also per-
formed using D562 cells. PPL siRNA-treated cells
showed a remarkable delay in wound closure compared
with control cells (Figure 4A and 4B). This delay in
wound closure could be caused by disturbance of cellu-
lar proliferation or migration. To discriminate between
these possibilities, we used time-lapse and video micro-
scopy after transfection of PPL siRNA to compare and
record cellular movement and migration (Figure 4C and
4D). As expected, PPL siRNA-treated cells showed a sig-
nificant decrease in motility and a shorter tracking
migration-length than controls (Additional file 3 and
Additional file 4). Moreover, we injected YES5 cells (low
PPL expression) and D562 cells (high PPL expression)
beneath the right thigh of nude mice and monitored
subsequent tumor growth. No tumor growth was
observed in YES5 mice, while some tumors were
observed in D562 mice (Additional file 5). These results
indicate that YES5 could not migrate into mice tissues
Tonoike et al. BMC Cell Biology 2011, 12:41
http://www.biomedcentral.com/1471-2121/12/41
Page 2 of 10
owing to its slow proliferation or weak adhesiveness to
ECM.
Knockdown of PPL decreases cellular migration via the
PI3K/Akt axis
Finally, we examined changes in the expression of phos-
pholipid signaling proteins that regulate cell migration
because PPL has been reported to play a role as a scaf-
fold in Akt/PKB signaling in human cancer cell lines [7].
The mitogen-activating protein kinase (MAPK) pathway
was also examined because PI3K/Akt/PKB and the path-
way are activated by G protein-coupled receptors
(GPCRs) that induce signaling events [9-11], and PPL
can also interact with a wide range of GPCRs and mod-
ulate their functions [12-14]. As expected, protein
expression of pAktSer473 was drastically downregulated
by PPL siRNA (Figure 4E). PPL also regulates keratin
organization and epithelial migration, participating in
the accumulation of keratin filaments to form thick
cables [15,16]. In our study, PPL siRNA reduced not
only the migration of assembled cells but also that of
single D562 cells with pAktSer473 suppression. These
data indicate that knockdown of PPL significantly
decreases cellular migration in D562 cells, at least partly
Figure 1 Downregulation of PPL by siRNA decreased the number of attached D562 cells. (A) PPL expression was detected in human
pharyngeal (D562 and FaDu) or esophageal (YES5, TE2, TE4, TE9, TE11, and T.Tn) cell lines by western blotting. (B) siRNA1 and siRNA2 against
PPL was shown in D562 cells. Total cell extracts were collected 72 h after siRNA treatment, and 5 μg protein aliquots were blotted with
antibodies against the indicated proteins. siRNA (GL2) against firefly luciferase was used as a control. b-actin was the internal control. (C)
Downregulation of PPL inhibited cell growth and decreased the number of attached cells. The number of viable cells was measured at different
times by trypan blue exclusion. Values represent the mean ± S.E. from 3 separate experiments. Asterisks (*) indicate a p value less than 0.01
based on a t-test using Day 5 data.
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Figure 2 siRNA against PPL delayed the cell cycle at the G2/M phase. D562 cells were transfected with control siRNA or siRNA 1 against
PPL. (A) Downregulation of PPL delayed cell cycle progression during the S and G2/M phases. Cells were harvested after 72 h, fixed, and
processed as described in “Materials and Methods.” DNA content was measured by flow cytometry after propidium iodide staining. (B) (C) Flow
cytometry analysis of cell cycle parameters was performed after double staining for BrdU incorporation (S phase cells) and 7-AAD (DNA content).
To measure direct cell cycle distributions in cell cycle phases, exponentially proliferating cells were labeled with 10 μM BrdU for 1 h and
processed for 2-color FACS, as described in “Materials and Methods.” Values represent the mean ± S.E. from 5 separate experiments. Asterisks (*)
indicate a p value less than 0.05 based on Student’s t-test.
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via the PI3K/Akt axis. Recent reports have indicated that
the PI3K/Akt axis is a central feature of EMT and that
Akt-induced EMT involves downregulation of E-cad-
herin [8,17]. As stated above, our results also showed
that siRNA against PPL suppressed pAktSer473 and
reduced cellular attachment activity.
PPL expression was different among normal, atypical
epithelium and cancer of the pharyngeal mucosa
If PPL expression relates to cellular migration, move-
ment or invasion, PPL expression should be different
among normal, atypical epithelium and cancers. Under
this hypothesis, we immunohistochemically examined
Figure 3 siRNA against PPL reduces adhesion to ECM in D562 cells. D562 cells were transfected with either control or PPL siRNA. (A) Effect
of downregulation of PPL by siRNA on the adhesive characteristics of D562 cells. After 48 h, cells were trypsinized and 2 × 104 cells were
resuspended in a 24-well plate coated with 200 μg of Matrigel. The plates were incubated at 37°C and adherent cells were counted. Four
random fields were counted in 2 separate wells and the results were averaged. Values represent the mean ± S.E. from 3 separate experiments.
Asterisks indicate a p value less than 0.05 based on Student’s t-test. (B) Snapshot from a time-lapse recording of 2 transfected wells. D562 cells
were transfected with either control siRNA (Additional file 1) or PPL siRNA (Additional file 2). Cells were grown to confluence in glass-bottomed
dishes and EDTA (2.5 mM final concentration) was added. Changes in the morphology of the culture were recorded by live imaging. Time-lapse
recordings were made every 5 min for 6 h. Bar: 200 μm.
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PPL expression in excised human normal, atypical
epithelium and in cancer of the pharyngeal mucosa (Fig-
ure 5). Interestingly, PPL was expressed in the upper
layer of the squamous epithelium in normal hypophar-
yngeal mucosa (Figure 5A, arrows), whereas PPL expres-
sion was rare in atypical hypopharyngeal epithelium
(Figure 5B, arrows). Note that in both the non-kerati-
nized (Figure 5C, asterisk) and keratinized cancer areas
(Figure 5C, arrows), PPL expression was scarce. Further
experiments are needed to determine how PPL relates
to EMT, including investigations of whether PPL knock-
down affects the expression of mesenchymal markers,
such as E-cahderin, fibronectin and/or N-cadherin.
Discussion
In this study, we revealed that siRNA against PPL signif-
icantly reduced the cellular motility and adhesion activ-
ity. In addition, PPL downregulation significantly
Figure 4 siRNA against PPL reduces cell migration in D562 cells. D562 cells were transfected with control and PPL siRNA. (A), (B)
Quantification of wound closure in control and PPL siRNA. Each cell was grown to confluence and then wounded by scraping. For each wound,
the width of the wound at 0 h was designated as 100%, and the subsequent timepoints in the graph show the relative width of the open
wound. Values represent the mean ± S.E. from 3 separate experiments. Asterisks indicate a p value less than 0.01 based on Student’s t-test. Bar:
200 μm. (C), (D) Paths of 2 transfected cells from a time-lapse recording. D562 cells were transfected with either control or PPL siRNA. After 24 h,
cells were seeded on glass-bottomed dishes and incubated for another 24 h. Time-lapse recordings were made every 5 min for 24 h. Migration
distance was measured using 10 control and 10 PPL siRNA-transfected cells. Bar: 100 μm. Asterisks indicate a p value less than 0.05 based on
Student’s t-test. (E) Downregulation of PPL resulted in reduced pAkt expression. The expression of PPL and b-actin was analyzed by western
blotting with total cell extracts from transient transfections with control siRNA (GL2) and PPL siRNA 1 and 2.
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decreased cellular migration, possibly because of PI3K/
Akt axis interference supported by a reduction in phos-
phorylated Akt at Ser473 (pAktSer473). Collectively,
PPL suppression reduced cell motility, and ECM inva-
sion, all of which generate tumor progression by
increasing infiltrating activity in pharyngeal squamous
cancer cells.
If PPL knockdown reduces cell adhesion activity, PPL
may be associated with proliferation and/or cell death
because homeostasis in epithelial cells is enforced by
their structural characteristics [18,19]. Furthermore, dis-
tortion of these balances by PPL siRNA, which interferes
with cell adhesion to ECM, is often associated with
epithelial tumorigenesis [20]. At this point, attachment
to ECM is essential to support cellular functions, includ-
ing differentiation, apoptosis, proliferation, and
migration.
In cancers, the hallmarks of EMT are the acquisition
of a migratory and invasive phenotype and/or anoikis
resistance, that is, accommodations for survival even in
the absence of adhesion to ECM [21,22]. In fibroblast
cells, Akt signaling enhances activation of various small
guanosine triphosphatases (GTPases), resulting in actin
cytoskeleton remodeling and enhanced cell motility
[23,24]. In this context, the dephosphorylation of Akt
and pAktSer473 induced by PPL siRNA (Figure 4E) is
enlightening. LY294002, a PI3K inhibitor, suppressed
cellular migration activity in D562 cell (Additional file
5). Since PI3K/Akt/mTOR pathway inhibition is
reported to decrease invasion and migration of ovarian
carcinoma cell lines [25,26], thus PPL siRNA potentially
decreased cellular attachment, migration or movement
at least partly via the PI3K/Akt axis.
Moreover, the effects of the matrix are primarily
mediated by integrins, a family of cell surface receptors
that attach cells to ECM and mediate mechanical and
chemical signals from ECM [27]. The PI3K/Akt axis is
positively regulated by integrins. Although further stu-
dies are necessary, the relationship among PPL, integ-
rins, and the integrin-plectin-vimentin complex
potentially bridges ECM and intracellular cytoskeletons
[17,28,29]. To investigate the integrins involved in this
impaired adhesiveness, a cell adhesion assay using other
substrates such as Poly-D/L-lysin, fibronectin, or type-I
collagen may be informative. For instance, apoptosis is
induced when cells are detached from the surrounding
ECM (anoikis) in normal cells [30]. However, cancer or
metastatic tumor cells can escape anoikis and thus
invade organs (anoikis resistance) [31]. Our results indi-
cate that PPL downregulation is accompanied by PI3K/
Akt axis interference which indicates EMT in pharyn-
geal cancers. In summary, the function of PPL relates to
cellular proliferation, cell cycle regulation, cellular move-
ment, and attachment to ECM at least partly via PI3K/
Akt axis.
Thus, knockdown of PPL reduced ECM attachment
and cellular proliferation. Further studies are required to
investigate the role of PPL as a candidate biomarker for
diagnosis and treatment of pharyngeal cancers.
Conclusion
The down-regulation of PPL significantly reduced cellu-
lar motility and adhesion activity along with phosphory-
lated AktSer473 suppression. Thus, PPL was positively
involved in cellular movement and attachment activity,
which was, at least partly achieved via the PI3K/Akt
Figure 5 Expression of PPL in normal, atypical epithelium and cancer of the pharyngeal mucosa. (A) In normal hypopharyngeal mucosa,
PPL is expressed in the upper layer of the squamous epithelium (arrows). (B) In atypical hypopharyngeal epithelium, PPL expression is rare
(arrows). (C) In the pharyngeal cancer epithelium, PPL expression is slight and occurs on the ridge of the cornified epithelium. Note that in both
the non-keratinized (asterisk) and keratinized cancer areas (arrows), PPL expression was scarce. Bar: 100 μm.
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axis. PPL knockdown is therefore related to reduced cel-
lular movement and attachment activity rather than
malignant progression, that is, PPL potentially partici-
pates in EMT in pharyngeal cancer cells.
Methods
Patients and tissue samples
Patients with pathologically proven hypopharyngeal
squamous cell carcinoma (all primary cases) hospitalized
at the Department of Otorhinolaryngology at Chiba
University Hospital were investigated in this study.
Written informed consent was obtained from each
patient prior to surgery.
Cell lines
The D562 pharyngeal cancer cell line was purchased
from Human Science Research Resources Bank, Osaka,
Japan. TE4, TE9, and TE11 human esophageal cancer
cell lines were provided by RIKEN BRC (National Bio-
Resource of the MEXT, Tsukuba, Japan) [32,33]. The
human esophageal cancer cell lines YES5, TE2, and TTn
were kindly provided by Dr. Shimada [34]. All cell lines
were cultured at 37°C in a humidified atmosphere con-
taining 5% CO2 and maintained in IMDM (Iscove’s
modified Dulbecco’s medium; Gibco BRL, NY, USA) in
tissue flasks supplemented with 10% heat-inactivated
FBS and penicillin (100 units/mL) as well as streptomy-
cin (0.1 mg/mL).
Transient siRNA transfection
Double-stranded siRNA oligonucleotides against PPL
and firefly luciferase (GL2), the negative control, were
purchased from QIAGEN (Hilden, Germany). Cells were
grown to 30-40% confluence in 24-well plates, and 20
pmol of siRNA oligonucleotides was transfected using
Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA,
USA). Cells were processed for each assay, and whole-
cell proteins were extracted 48-72 h after transfection.
Knockdown efficiency of PPL by siRNA was assessed by
immunoblotting.
Immunoblotting
Cells were dissolved in lysis buffer (7 M urea, 2 M
thiourea, 2% 3-[(3-cholamidopropyl)dimethylammonio-]
1-propanesulfate, 0.1 M dithiothreitol, 2% IPG buffer
(GE Healthcare, Buckinghampshire, UK), and 40 mM
Tris) using a Polytron homogenizer (Kinematica, Swit-
zerland) following centrifugation (100,000 × g) for 1 h at
4°C. The amount of protein in the supernatant was
measured by protein assay (Bio-Rad, Hercules, CA,
USA). The proteins were separated by electrophoresis
on 7.5% polyacrylamide gels and transferred to a polyvi-
nylidene fluoride membrane (Millipore, Bedford, MA,
USA) in a tank transfer apparatus (Bio-Rad, Hercules,
CA, USA). The membrane was blocked with 0.5% skim
milk in phosphate-buffered saline (PBS) or 0.5% bovine
serum albumin (BSA) in tris-buffered saline with Tween
20 (TBST) for 1 h, and probed with a primary antibody
diluted in blocking buffer. Anti-PPL (Betyl Laboratory
Ltd., Montgomery, TX, USA), anti-phospho-AKT
(Ser473 or Thr308), anti-phospho-MAPK (Cell Signaling
Technology, Beverly, MA, USA), and anti-b-actin (Santa
Cruz, CA, USA) were used as primary antibodies. Don-
key anti-rabbit IgG horseradish peroxidase (HRP) conju-
gate (Amersham Pharmacia Biotech, Piscataway, NJ,
USA) diluted 1:3,000 and rabbit anti-goat IgG HRP
(Cappel, West Chester, PA, USA) diluted 1:500 were
used as secondary antibodies. Antigens on the mem-
brane were detected by ECL™ detection reagents (GE
Healthcare, Buckinghamshire, UK).
Proliferation assay
Five thousand cells were seeded in 24-well Falcon 3072
plates (Becton Dickinson, Lincoln Park, NJ, USA) at 37°
C and 5% CO2. After various periods, cell number was
established by counting with a phase-contrast Leitz
microscope (MD, USA).
Flow cytometry
For cell cycle analysis, 1 × 106 cells were seeded in 10-
cm-diameter culture dishes. Cells were trypsinized,
washed with ice-cold PBS, fixed in 70% ethanol, and
stored at -20°C. The cells were then treated with RNase
(0.2 mg/mL) for 0.5 h at 37°C and stained with propi-
dium iodide at 50 μg/mL. The stained cells were analyzed
in a FACSCalibur cytometer (Becton Dickinson, Lincoln
Park, NJ, USA), and the results were analyzed with
FlowJo software (Tree Star Inc., San Carlos, CA, USA).
BrdU incorporation assay
The BrdU incorporation assay was carried out as
described previously, using the BrDu flow kit (Becton
Dickinson, Lincoln Park, NJ, USA) according to the man-
ufacturer’s instructions [35]. In brief, 1-2 × 106 cells were
labeled with 10 μM BrdU for 1 h, harvested, fixed, and
treated with DNAase. Cells were stained with anti-BrdU
FITC-coupled antibody and 7-AAD for DNA. Samples
were analyzed in a FACSCalibur cytometer (Becton Dick-
inson, Lincoln Park, NJ, USA) using the FlowJo program
(Ashland, OR, USA). BrdU signals were recorded on a
logarithmic scale in the FL1 channel, and DNA was
recorded on a linear scale in the FL3 channel. Single cell
events were distinguished from cell aggregates on a FL3-
A versus FL3-W plot of 7-AAD fluorescence.
Wound-healing assay
Cells were transfected with PPL siRNA or pretreated for
2 h with PI3K inhibitor, LY294002 (Wako, Osaka,
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Japan). Then, cells were grown to confluence in 6-well
plates, and monolayer cells were scraped using a micro-
pipette (yellow) tip. After washing with PBS, serum-free
medium was added to prevent cell proliferation. Photo-
graphs of the wounded area were taken immediately
after the scratch was made. Six and 24 h after scraping,
cell movement into the wounded area was monitored by
time-lapse microscopy.
Adhesion assay
Adhesion of PC-3 cells was measured as described pre-
viously, with some modifications [36,37]. In brief, each
well of a 24-well plate was coated with 200 μg/ml Matri-
gel (Becton Dickinson, Lincoln Park, NJ, USA). In each
well, 2 × 104 cells were added in 0.5 mL serum-free
media supplemented with 0.1% BSA. The plates were
incubated at 37°C and adhesion was determined at 0.5
h. The plates were fixed with methanol and stained with
Diff-Quik (Sysmex Corp., Kobe, Japan). The number of
cells adhered to the Matrigel was counted at 4 random
fields per well in duplicate at a magnification of ×400.
Time-lapse microscopy
Time-lapse recordings of cells were made with an Axio-
vert 200 M SP LSM 510 META confocal laser scanning
microscope (Carl Zeiss Inc., Oberkechen, Germany)
equipped with an AxioCam charge-coupled device
(CCD) camera (Zeiss, Germany) and AxioVision soft-
ware. Cells were maintained in an environmental cham-
ber at 37°C with 5% CO2 during the analysis. Images
were taken by CCD camera through a laser scanning
microscope every 5 min. Cell tracking was performed
using AxioVision software. Images were imported into
Adobe Photoshop and prepared as pictures.
Immunohistochemical staining
Immunohistochemical procedures for PPL expression
have been described previously [38]. In brief, air-dried
4-micron cryostat sections were fixed in cold acetone
for 20 min and washed with PBS for 5 min. The sec-
tions were then incubated with anti-PPL antibody over-
night at 4°C. After washing with PBS, the sections were
incubated with biotinylated anti-rabbit IgG as a second-
ary antibody. The sections were then incubated with
HRP-conjugated streptavidin-biotin complex for 0.5 h.
Peroxidase activity was visualized by DAB solution (20
mg of 3,3’-diaminobenzidine, 65 mg of sodium azide,
and 10 mL of 30% hydrogen peroxide in 100 mL of 0.05
M Tris buffer at pH 7.6). Hematoxylin was used for
nuclear counterstaining.
Statistical Analysis
The abovementioned experiments were repeated at least
3 times. Student’s t-test was used for statistical analysis.
Additional material
Additional file 1: Adhesion assay of D562 cells.
Additional file 2: siRNA against PPL reduces adhesion to ECM in
D562 cells. D562 cells were transfected with either control siRNA
(Additional file 1) or PPL siRNA (Additional file 2). The cells were grown
to confluence in glass-bottomed dishes and EDTA (2.5 mM final
concentration) was added. Images were analyzed by time-lapse confocal
laser scanning microscopy using a laser-scanning confocal microscope
(LSM 510 META; Carl Zeiss Inc). Frames were taken every 5 min for 6 h.
Additional file 3: Migration of D562 cells.
Additional file 4: siRNA against PPL reduces cell migration in D562
cells. D562 cells were transfected with either control siRNA (Additional
file 3) or PPL siRNA (Additional file 4). After 24 h, cells were seeded on
glass-bottomed dishes and incubated for another 24 h. Images were
analyzed by time-lapse confocal laser scanning microscopy using a laser-
scanning confocal microscope. Frames were taken every 5 min for 24 h.
Additional file 5: pAktSer473 phosphorylation affects cellular
movement in D562 cells. (A) (B) 5 × 105 YES5 cells (low PPL expression)
and D562 cells (high PPL expression) were injected beneath right thigh
of 8-week male nude mice and monitored subsequent tumor growth.
No tumor growth was observed in YES5 mice, while some tumors were
observed in D562 mice. (C) LY294002, a PI3K inhibitor, suppressed
pAktSer473 phosphorylation but did not alter PPL expressio in D562 cells.
(D) LY294002 suppressed D562 cell migration revealed by wound-healing
assay in D562 cells. (E) The ratio of width at 6 hrs/0 hr (%) indicated that
LY294002 suppressed wound-healing in D562 cells.
Abbreviations
PPL: periplakin; siRNAs: short interfering RNAs; PKB: protein kinase B; EMT:
epithelial-mesenchymal transition; ECM: extracellular matrix; PI3K:
phosphatidylinositol 3’ kinase.
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